SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders. Founded by Joseph Higgins in 2020, SalioGen Therapeutics is backed by PBM Capital Group and is headquartered in Burlington.
FOUNDED:
2020
INDUSTRY:
Biotechnology, Genetics, Life Science, Therapeutics
FOUNDERS:
Joseph Higgins
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
